Investor Type | Firm |
Type of Fund | Private Equity Fund |
Industries | Other • IT (& TMT) • BioTech • Material Science • Medical Devices (& Hospital Services) • Life Science |
Investing | United States • United Kingdom • Germany • Europe |
Cycad Group LLC is a private equity fund based in London, United Kingdom, specializing in equity investments across a range of industries including IT, BioTech, Material Science, Medical Devices, Hospital Services, and Life Sciences. While the fund operates under the umbrella of TPG, a global alternative asset manager managing $239 billion in assets, Cycad Group maintains a unique position by leveraging TPG's extensive resources and network. TPG itself was founded in 1992 and has since grown organically and through strategic acquisitions. With over 1800 employees, TPG operates in more than 30 countries and prides itself on its sector-specific expertise, collaborative culture, and an innovative approach to investment. Their strategies cover a wide spectrum including private equity, impact investing, credit, real estate, and market solutions, with several platforms such as TPG Capital, TPG Growth, TPG Impact, TPG Angelo Gordon, and TPG Real Estate. As part of their engagement, TPG focuses on environmental, social, and governance (ESG) principles, striving for diversity, equity, and inclusion within their investments and operations. Cycad Group LLC takes advantage of TPG's insights and expertise, positioning itself as a knowledgeable investor within its chosen sectors. While Cycad Group leverages the broader capabilities of TPG, they focus on the creation of long-term value through partnership with innovative and growth-oriented companies, aligning financial success with societal impact.